Navigation Links
Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share
Date:11/10/2009

- 8.5% Special Items ($31) ($30) ($225) ($34) Operating Income Before Special Items $96 $101 (5%) $293 $359 (18%) Operating Margin Before Special Items 10.6% 10.0% 8.5% 9.4%

Revenue of $904 million declined 11% in the quarter with an organic revenue decline of 7%. Service revenue declined 5% organically and installation revenue declined 8% driven by continued softness in the North American and EMEA regions. Backlog of $1.2 billion decreased 5% on a quarter sequential basis (a 7% decline excluding the impact of foreign currency).

Operating income was $65 million in the quarter and the operating margin was 7.2%. Special items of $31 million resulted from restructuring activities. Operating income before special items was $96 million and the operating margin before special items improved 60 basis points to 10.6% as cost-containment actions more than offset the decline in revenue.

Full year revenue of $3.4 billion decreased 11% primarily due to changes in foreign currency with an organic revenue decline of 3%. Operating income was $68 million and included $225 million of special items. Operating income before special items of $293 million decreased $66 million primarily due to lower volume and a $12 million negative foreign currency impact.

Electrical and Metal Products

                           Q4 2009  Q4 2008 % Change FY 2009 FY 2008 % Change
                           -------  ------- -------- ------- ------- --------
    Revenue                   $326     $591     (45%) $1,392  $2,272   (39%)
     Operating Income          $12      $88     (86%)  ($940)   $342      -
     Operating Margin          3.7%    14.9%               -    15.1%
     Special Items             ($9)    ($31)           ($957)   ($43)
     Operating Income Before
      Special Items            $21     
'/>"/>
SOURCE Tyco International Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research
2. Tyco International to Present at the Citi Industrial Manufacturing & Transportation Conference
3. AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation
4. HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
5. Allied Worlds Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference
6. Service Corporation International Announces Third Quarter 2009 Financial Results
7. Stenum Hospital Kicks off International Rollout of M6 Artificial Lumbar Disc Replacement Surgery
8. FDA CONSUMER HEALTH INFORMATION UPDATES: Fraudulent H1N1 flu products, hearing aids, sound amplifiers, tobacco regulation, FDAs international posts, LASIK eye surgery, and FDA MedWatch safety alerts
9. Service Corporation International Announces Schedule for Its Third Quarter 2009 Earnings Release and Conference Call
10. Blue Cross and Blue Shield of Floridas Power of the Human Voice Campaign Wins Prestigious DMA International ECHO Gold Award
11. MediSend International Joins the Clinton Global Initiative With the Afghanistan Health and Human Resource Initiative

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...od pressure readings in children with chronic kidn... during doctor,s office visits increasing a child...esearch from Johns Hopkins Children,s Center and o...s online in the Journal of American Society of Nep... measurements obtained during regular doctor visit...
(Date:11/20/2009)...nks it,s as short as 34 weeks, potentially adding ..., FRIDAY, Nov. 20 (HealthDay News) -- Recent repor...ues to climb in the United States. Now, a new stu...d about what constitutes a full-term birth in the ... surveyed in the study considered a baby born at 3...
(Date:11/20/2009)...ctivity remains high and is expected to continue, ...y News) -- Some areas of the United States are see... health official said Friday, and while the diseas...m the 46 states reported last week. , "We are b...y around the country, but there is still a lot of ...
(Date:11/20/2009)... SPRINGFIELD, Mo., Nov. 20 Missour...al Missouri regions will now have the option to ch...ched Tuesday between Missouri Consolidated Health ...e Southwest and South Central Missouri regions inc... Christian, Dade, Dallas, Douglas, Greene, Hickory...
(Date:11/20/2009)... BATON ROUGE, La., Nov. 20 /PRNewswire-USNewswir...(LAHP) today warned that Louisianians could experi...its if proposals being considered by Congress shou... executive officer for LAHP, "Louisiana health pla... since the beginning of the national debate. Our ...
Breaking Medicine News(10 mins):Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2
...7 Merck & Co., Inc.,today said that it has not ye...k State and New York City seeking Medicaid reimbur...t the suit as it has defended against the,Medicaid...ug Administration (FDA) approval, and consistently...
...or Living,Inc. (NYSE: BKD ) announced today that ...sh dividend on its common stock of $0.50 per share....50 per share dividend is payable,on October 12, 2...ving facilities throughout the United States. The ...
...Biosciences,Inc. (LSE: AKR) which develops, manufa...g and testing products, is pleased to announce tha...Army for the purchase of its,BreathScan alcohol sa...gnificant,orders from several departments of the U...
... Focus on Cardiovascular Disease, Prevention and ...e Care Improvements, ...Charlie,Rose Science Series" on PBS will focus on ...l Laureate and President of,Rockefeller University...
...hat patients with cancer in the head and neck regi...kills compared with individuals without the diseas... Archives of Otolaryngology-Head & Neck Surgery, o...ork together. These functions can be compromised t...
...rday, October 20,Event to be held in honor of Octo...PLAINS, Mo., Sept. 17 GAMMILL QUILTING SYSTEMS, a...ngarm quilting systems, in,cooperation with it,s n...tional Breast Cancer Awareness Month; and in,suppo...
Other Medicine News:Health News:Merck & Co., Inc. Response to Today's New York Medicaid Suit 2Health News:Merck & Co., Inc. Response to Today's New York Medicaid Suit 3Health News:Akers Biosciences, Inc. 'ABI' or the 'Company' Receipt of Further United States Military Contracts 2Health News:Charlie Rose Science Series Explores Heart Disease 2Health News:Charlie Rose Science Series Explores Heart Disease 3Health News:Patients with head and neck cancer may have impairment of some driving skills 2Health News:'Think Pink with Gammill(R)' 2
(Date:11/20/2009)... Nov. 20 Reportlinker.com announce...n its catalogue. ,, Medical Adhesives and Seal...rtlinker.com/p0164242/Medical-Adhesives-and-Sealan...&utm_medium=pr&utm_campaign=prnewswire ,...gaining preeminence in medical devices and equipme...
(Date:11/20/2009)..., N.J., Nov. 20 BD (Bect...nounced the completion of its acquisition of Handy...at develops and manufactures molecular diagnostic ..., BD and HandyLab announced an exclusive agreement...ays on the HandyLab Jaguar(TM) platform, the first...
(Date:11/19/2009)...Nov. 19 In response to an ever-inc... illegal medicines, Operation Pangea II, involving... World Health Organization,s International Medical...o highlight the dangers of buying medicines online...n a series of arrests and the seizure of thousands...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Announcing Sustainability in Packaging 2010 3A Strategies to make sustainability sustainable 13946 1Announcing Sustainability in Packaging 2010 3A Strategies to make sustainability sustainable 13946 2Announcing Sustainability in Packaging 2010 3A Strategies to make sustainability sustainable 13946 3First Cape Cod Macular Degeneration Symposium To Be Held on September 17 56628 1First Cape Cod Macular Degeneration Symposium To Be Held on September 17 56628 2First Cape Cod Macular Degeneration Symposium To Be Held on September 17 56628 3Michigan Pre Seed Capital Fund Awards Three Micro Loans 13945 1Michigan Pre Seed Capital Fund Awards Three Micro Loans 13945 2
...Nova BioSciences, Inc.,("CeloNova"), leading and a...sion and development of innovative medical devices... 8 country European study of uterine fibroid,embol...res. The study,results were reported at the 20th A...apy., (Photo: http://www.newscom.com/cgi-bin/prn...
...on for HUMIRA Provides Patients with Visible, Cle...Autoimmune Disease, ABBOTT PARK, Ill., Jan. 18 A...d U.S. Food and Drug Administration (FDA),approval...or adult patients,with moderate to severe chronic ...zed by skin lesions that are sometimes painful and...
Other Medicine Technology:CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids 2Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 2Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 3Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 4Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 5Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 6Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 7
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: